Journal of Natural Products · 1993 · 127 citations · 0 references
PharmacyMedicinal ChemistryPharmacologyBiochemical PharmacologyDrug DiscoveryStructure-activity RelationshipsInflammation PharmacologyMarine Bioactive CompoundsMarine Drug DiscoveryMarine PharmacologyReceptor PharmacologyStructure-activity Relationship AnalysisImidazole AlkaloidsImidazole ChemistryLeukotriene PharmacologyLeukotriene Receptor PharmacologyMarine AlkaloidsMarine Sponge MetabolitesMarine-derived Anti-inflammatory CompoundsStructure-based Lead Discovery
Three new imidazole alkaloids, leucettamines A [1] and B [2] and leucettamidine [3], have been isolated from the Palauan sponge Leucetta microraphis. Their structures were established on the basis of extensive spectral analyses. Leucettamine A showed potent leukotriene B4 receptor binding activity (K(i) = 1.3 microM), while leucettamine B was essentially inactive (K(i) = 100 microM) and leucettamidine showed significant activity (K(i) = 5.3 microM). With leucettamine A identified as a pure LTB4 receptor antagonist, a new structure lead is presented to inflammation therapy.